FAQs

We prefer opportunities where we can expect a holding period that is below five years, but in certain cases we are willing to support companies up to the most adequate exit.

The fund will typically invest USD 10-30m over the lifetime of an investment through multiple rounds. We always ensure that we have reserves if required, and we can provide guidance on securing additional financing, as well as bringing in other investors from our network. Beyond capital, we support companies in [...]

We invest in transformative healthcare technologies that can significantly improve patient outcomes or streamline healthcare delivery. Specifically, we invest in medical devices, diagnostics and digital health. We invest in growth stage, commercially ready companies that are either already on the market or have a predictable path towards market entry. Where [...]

We generally look to hold a stake of 10-25%. We usually take a seat on the board of directors to ensure we have a complete overview of the business and can bring value, for example, in providing access to our network or giving strategic guidance. We understand the importance of [...]

Most of our investments have been in the US and Europe, but we don’t restrict ourselves by geography and will consider proposals that meet our investment criteria regardless of where the company is based.

We approach it from several angles. We apply valuation techniques specific to young companies such as the venture capital method, cash flow valuation or earnings valuation. We also compare the potential deal with other companies and their typical market valuation. Finally, we undertake a qualitative assessment of the operational elements [...]

We focus on building fully-fledged standalone companies capable of reaching >USD 100m in annual revenues. However, as is common in healthcare, private specialised companies are often acquired by global strategics through a trade sale which provides an exit opportunity. A company may also be a good target for a public [...]

In 2016, we closed our first fund dedicated to medtech and digital health, Endeavour Medtech Growth (EMG) LP, with a total fund size of USD 280m. In 2021, we closed EMG II LP with a total committed capital of USD 375m. EMG II LP is focused on investments in medical [...]

ESG is a sustainable investment practice that considers the impact and risks of environmental, social and governance (ESG) factors, as well as potential financial return in a project or company. To provide an ESG score, independent rating agencies will evaluate company practices and risk profiles. An organisation with a [...]

All three terms refer to different types of sustainable investment and can be distinguished in the following ways: ESG investing aims to create long-term wealth by focusing on core environmental, social and governance criteria. This is based on the premise that companies employing such focused and sustainable business practices tend [...]